Randomised trial of lymphoblastoid α-interferon in chronic hepatitis C: Effects on inflammation, fibrogenesis and viremia
Authors:
- Alberto CastillaACAlberto Castilla
- Juan RuizJRJuan Ruiz
- María P. CiveiraMCMaría P. Civeira
- Jesús PrietoJPJesús Prieto
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 17 (3) , 390-396
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Therapy of chronic hepatitis C with α-interferon: The answer? Or more questions?Hepatology, 1991
- Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitisJournal of Hepatology, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus AntibodiesScandinavian Journal of Infectious Diseases, 1989
- Colchicine in the Treatment of Cirrhosis of the LiverNew England Journal of Medicine, 1988
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patientsDigestive Diseases and Sciences, 1986
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981